J. Scott Wolchko - Oct 21, 2021 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Role
President and CEO, Director
Signature
/s/ Cindy Tahl, as Attorney-in-Fact
Stock symbol
FATE
Transactions as of
Oct 21, 2021
Transactions value $
-$3,399,389
Form type
4
Date filed
10/25/2021, 04:04 PM
Previous filing
Aug 20, 2021
Next filing
Nov 22, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FATE Common Stock Options Exercise $81.9K +30K +7.62% $2.73 424K Oct 21, 2021 Direct F1
transaction FATE Common Stock Sale -$911K -15.2K -3.59% $59.82* 409K Oct 21, 2021 Direct F1, F2
transaction FATE Common Stock Sale -$895K -14.8K -3.61% $60.63* 394K Oct 21, 2021 Direct F1, F3
transaction FATE Common Stock Options Exercise $27.3K +10K +2.54% $2.73 404K Oct 22, 2021 Direct F1
transaction FATE Common Stock Options Exercise $23.5K +4.85K +1.2% $4.84 409K Oct 22, 2021 Direct F1
transaction FATE Common Stock Options Exercise $40.9K +15.2K +3.71% $2.70 424K Oct 22, 2021 Direct F1
transaction FATE Common Stock Sale -$1.77M -30K -7.08% $58.88* 394K Oct 22, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FATE Stock Option (Right to Buy) Options Exercise $0 -30K -33.33% $0.00 60K Oct 21, 2021 Common Stock 30K $2.73 Direct F1, F4
transaction FATE Stock Option (Right to Buy) Options Exercise $0 -10K -16.67% $0.00 50K Oct 22, 2021 Common Stock 10K $2.73 Direct F1, F4
transaction FATE Stock Option (Right to Buy) Options Exercise $0 -4.85K -100% $0.00* 0 Oct 22, 2021 Common Stock 4.85K $4.84 Direct F1, F4
transaction FATE Stock Option (Right to Buy) Options Exercise $0 -15.2K -13.22% $0.00 99.4K Oct 22, 2021 Common Stock 15.2K $2.70 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.31 to $60.30 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.31 to $61.26 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 This option is fully vested.